Literature DB >> 23979832

Down-regulation of HAI-1 is associated with poor-differentiation status of colorectal cancer.

Jingjia Ye1, Haixia Cheng, Yi Wang, Jiang Cao.   

Abstract

Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is a Kunitz-type serine protease inhibitor which is widely expressed in epithelial cells. The purpose of this study is to investigate the relationship between HAI-1 expression and differentiation status of colorectal epithelia. The expression of HAI-1 in clinical samples of both cancerous and normal colorectal tissues was evaluated by immunohistochemical staining. An in vitro epithelial differentiation model of Caco-2 cell was established, and the characteristics of differentiation of Caco-2 cells were observed by transmission electron microscopy. The expression of HAI-1 in Caco-2 cells at different differentiation stages was examined by western blot. Immunohistochemical staining of 52 human colorectal cancer tissues showed a definite correlation between HAI-1 expression and differentiation status: IHC score (mean ± SE) of HAI-1 was higher for well- or moderately-differentiated colorectal cancer tissues than for poorly-differentiated colorectal cancer tissues, with significant differences in HAI-1 positive rate (P < 0.01 and P < 0.05 for well-differentiated vs. poorly-differentiated and moderately-differentiated vs. poorly-differentiated, respectively). Immunohistochemical staining of normal colorectal tissues showed positive HAI-1 expression in well-differentiated epithelial cells whereas the under-differentiated crypt cells showed very weak HAI-1 staining signals. The result of western blot also showed the gradual increasing of HAI-1 expression during the process of Caco-2 differentiation in vitro. HAI-1 expression correlates with the differentiation status of colorectal epithelia and could serve as a differentiation marker.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23979832     DOI: 10.1007/s13577-013-0074-7

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  26 in total

1.  TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.

Authors:  Tomio Hashimoto; Minoru Kato; Takeshi Shimomura; Naomi Kitamura
Journal:  FEBS J       Date:  2010-10-26       Impact factor: 5.542

2.  Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1.

Authors:  Kimitoshi Denda; Takeshi Shimomura; Toshiya Kawaguchi; Keiji Miyazawa; Naomi Kitamura
Journal:  J Biol Chem       Date:  2002-01-22       Impact factor: 5.157

3.  [Effect of HAI-1 over-expression on in vitro growth and migration/motility of SW620 cells].

Authors:  Jiang Cao; Jing Jia Ye
Journal:  Shi Yan Sheng Wu Xue Bao       Date:  2005-06

4.  Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract.

Authors:  Lei Zeng; Jiang Cao; Xing Zhang
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

5.  Membrane-bound serine protease inhibitor HAI-1 is required for maintenance of intestinal epithelial integrity.

Authors:  Makiko Kawaguchi; Naoki Takeda; Shinri Hoshiko; Kenji Yorita; Takashi Baba; Akira Sawaguchi; Yuriko Nezu; Tsutomu Yoshikawa; Tsuyoshi Fukushima; Hiroaki Kataoka
Journal:  Am J Pathol       Date:  2011-08-12       Impact factor: 4.307

6.  Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.

Authors:  H Kataoka; R Hamasuna; H Itoh; N Kitamura; M Koono
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

7.  Regulation of the matriptase-prostasin cell surface proteolytic cascade by hepatocyte growth factor activator inhibitor-1 during epidermal differentiation.

Authors:  Ya-Wen Chen; Jehng-Kang Wang; Feng-Pai Chou; Chiu-Yuan Chen; Ellen A Rorke; Li-Mei Chen; Karl X Chai; Richard L Eckert; Michael D Johnson; Chen-Yong Lin
Journal:  J Biol Chem       Date:  2010-08-09       Impact factor: 5.157

8.  Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer.

Authors:  Jung Y Kang; Marisa Dolled-Filhart; Idris Tolgay Ocal; Baljit Singh; Chen-Yong Lin; Robert B Dickson; David L Rimm; Robert L Camp
Journal:  Cancer Res       Date:  2003-03-01       Impact factor: 12.701

Review 9.  The matriptase-prostasin proteolytic cascade in epithelial development and pathology.

Authors:  Gregory S Miller; Karin List
Journal:  Cell Tissue Res       Date:  2012-02-18       Impact factor: 5.249

10.  The hepatocyte growth factor regulatory factors in human breast cancer.

Authors:  Christian Parr; Gareth Watkins; Robert E Mansel; Wen G Jiang
Journal:  Clin Cancer Res       Date:  2004-01-01       Impact factor: 12.531

View more
  1 in total

Review 1.  Mechanisms of hepatocyte growth factor activation in cancer tissues.

Authors:  Makiko Kawaguchi; Hiroaki Kataoka
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.